Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Janssen Korea, Ltd., Korea

Clinicaltrial registered22 Oct 2026

Janssen Korea, Ltd., Korea

22 Oct 2026: Trial registered · A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in Korea. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
22 Oct 2026
Title
A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in Korea
Conditions
Pulmonary Arterial Hypertension
Study Type
Observational
Status
Not Yet Recruiting
Countries
South Korea
Country
South Korea
Reference
NCT07890285
Location
South Korea
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Janssen Korea, Ltd., Korea

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from South Korea

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.